5-HYDROXYTRYPTAMINE METABOLISM IN ACQUIRED HEART-DISEASE ASSOCIATED WITH ARGENTAFFIN CARCINOMA
- 12 November 1955
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 266 (6898), 1016-1017
- https://doi.org/10.1016/s0140-6736(55)93436-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Observations on the fate of indolalkylamines in the organismThe Journal of Physiology, 1955
- ARGENTAFFINOMA AS ENDOCRINE TUMOURThe Lancet, 1955
- PAROXYSMAL FLUSHING AND OTHER SYMPTOMS CAUSED BY 5-HYDROXYTRYPTAMINE AND HISTAMINE IN PATIENTS WITH MALIGNANT TUMOURSThe Lancet, 1954
- Über den Nachweis von 5-Oxytryptamin (Enteramin, Serotonin) in CarcinoidmetastasenNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1954
- 5-Hydroxytryptamine in a Carcinoid TumourNature, 1953
- The Variable Arterial Pressure Response to Serotonin in Laboratory Animals and ManCirculation Research, 1953
- Reflex and Direct Cardiopulmonary Effects of 5-OH-Tryptamine (Serotonin)American Journal of Physiology-Legacy Content, 1953
- Tryptamine receptorsThe Journal of Physiology, 1953
- Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiographyAmerican Heart Journal, 1952
- Nature of the Lung Enzyme which inactivates Serum VasoconstrictorNature, 1950